Metabolic disturbances and obesity are major cardiovascular risk factors in patients with
schizophrenia, resulting in a higher mortality rate and shorter life expectancy compared with …

The present study aims at comparing the change in cytokine levels in schizophrenia patients
treated with atypical antipsychotics, with or without metabolic syndrome (MetS). The study …

Background: Observational studies that have supported the role of the leptin level in
schizophrenia (SCZ) risk are conflicting. Therefore, we performed a two-sample Mendelian …

Atypical antipsychotics (AAPs) are primary medications for schizophrenia (SZ). However,
their use is frequently associated with the development of adverse metabolic effects, and the …

Нейросоциальное «Золотое сечение» новой личности сформировано на современных
нейротеориях нарушений мышления и памяти, и основано на гетерогенной и …

Background: Individuals with a diagnosis of schizophrenia are known to be at high risk of
premature mortality due to poor physical health, especially cardiovascular disease …

Objectives To investigate the association between cytokine peripheral levels and the risk of
cardiovascular disease in patients with schizophrenia and controls. Methods A sample of 40 …

Schizophrenia is a multifactorial mental disorder, characterized by positive symptoms
(delusions, hallucinations), negative symptoms (anhedonia, social withdraw), and cognitive …

Skizofrenia adalah gangguan fungsi mental dengan gejala gangguan persepsi (delusi,
waham), dan gangguan realitas. Terapi untuk skizofrenia adalah antipsikotik. Rekomendasi …

Background In this cross‐sectional study, we compared fasting serum asprosin levels and
metabolic parameters between patients receiving one of three atypical antipsychotics …